Envestnet Asset Management Inc. Has $1.55 Million Stock Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Envestnet Asset Management Inc. trimmed its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 11.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,721 shares of the company’s stock after selling 2,332 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.55% of Invesco Pharmaceuticals ETF worth $1,547,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in PJP. Jones Financial Companies Lllp boosted its stake in shares of Invesco Pharmaceuticals ETF by 195.7% during the fourth quarter. Jones Financial Companies Lllp now owns 2,176 shares of the company’s stock valued at $180,000 after purchasing an additional 1,440 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Invesco Pharmaceuticals ETF by 241.7% during the third quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after purchasing an additional 2,862 shares in the last quarter. Grimes & Company Inc. bought a new position in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth about $354,000. Commonwealth Retirement Investments LLC bought a new position in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth about $401,000. Finally, Raymond James Financial Inc. bought a new position in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth about $943,000.

Invesco Pharmaceuticals ETF Price Performance

Shares of PJP opened at $80.67 on Tuesday. Invesco Pharmaceuticals ETF has a 1 year low of $72.25 and a 1 year high of $89.87. The company has a market capitalization of $242.82 million, a price-to-earnings ratio of 19.60 and a beta of 0.56. The business has a 50-day moving average of $82.39 and a 200-day moving average of $84.41.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.